139 related articles for article (PubMed ID: 37204106)
21. Human Papillomavirus Vaccination as an Adjuvant Therapy for Recurrent Respiratory Papillomatosis: Additional Case Series.
Matsuzaki H; Makiyama K; Hasegawa H; Asai R; Morita M; Oshima T
J Voice; 2024 Jan; 38(1):204-209. PubMed ID: 34600799
[TBL] [Abstract][Full Text] [Related]
22. Molecular subtypification of human papillomavirus in male adult individuals with recurrent respiratory papillomatosis.
García-Romero CS; Akaki-Caballero M; Saavedra-Mendoza AG; Guzmán-Romero AK; Canto P; Coral-Vázquez RM
Auris Nasus Larynx; 2015 Oct; 42(5):385-9. PubMed ID: 25906915
[TBL] [Abstract][Full Text] [Related]
23. Immunological tolerance of low-risk HPV in recurrent respiratory papillomatosis.
Ivancic R; Iqbal H; deSilva B; Pan Q; Matrka L
Clin Exp Immunol; 2020 Feb; 199(2):131-142. PubMed ID: 31628850
[TBL] [Abstract][Full Text] [Related]
24. Spontaneous Regression of Recurrent Respiratory Papillomatosis with HPV Vaccination: A Case Study.
Nyirjesy S; Osmundson P; Matrka L
J Voice; 2022 Jul; 36(4):587.e21-587.e25. PubMed ID: 32891477
[TBL] [Abstract][Full Text] [Related]
25. The impact of cidofovir treatment on viral loads in adult recurrent respiratory papillomatosis.
Mikolajczak S; Quante G; Weissenborn S; Wafaisade A; Wieland U; Lüers JC; Klussmann JP; Beutner D
Eur Arch Otorhinolaryngol; 2012 Dec; 269(12):2543-8. PubMed ID: 22766836
[TBL] [Abstract][Full Text] [Related]
26. Systematic review of the use of human papillomavirus vaccine as adjuvant therapy for juvenile-onset recurrent respiratory papillomatosis.
Park I; Carbone S; Preciado D
Int J Pediatr Otorhinolaryngol; 2022 Nov; 162():111314. PubMed ID: 36116179
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of human papillomavirus 6 and 11 variants in recurrent respiratory papillomatosis.
Sichero L; Ferreira S; López RVM; Mello BP; Costa V; El-Achkar VNR; Carlos R; Ribeiro-Silva A; Pignatari S; Kaminagakura E; Villa LL
J Med Virol; 2021 Jun; 93(6):3835-3840. PubMed ID: 32910471
[TBL] [Abstract][Full Text] [Related]
28. Role of epstein-barr virus in the severity of recurrent respiratory papillomatosis.
Costa V; El-Achkar VN; de Barros PP; León JE; Ribeiro-Silva A; Carlos R; Pignatari SSN; Ferreira S; Mello BP; Sichero L; Villa LL; Kaminagakura E
Laryngoscope; 2020 Nov; 130(11):E611-E618. PubMed ID: 31860132
[TBL] [Abstract][Full Text] [Related]
29. Intralesional cidofovir injection for recurrent respiratory papillomatosis in Japan.
Murono S; Nakanishi Y; Tsuji A; Endo K; Kondo S; Wakisaka N; Yoshizaki T
Auris Nasus Larynx; 2016 Oct; 43(5):541-5. PubMed ID: 26860235
[TBL] [Abstract][Full Text] [Related]
30. Estimating the prevalence of and treatment patterns for juvenile onset recurrent respiratory papillomatosis in Australia pre-vaccination: a pilot study.
Novakovic D; Cheng AT; Cope DH; Brotherton JM
Sex Health; 2010 Sep; 7(3):253-61. PubMed ID: 20719212
[TBL] [Abstract][Full Text] [Related]
31. Implementation of Routine HPV Vaccination in the Management of Recurrent Respiratory Papillomatosis.
Yiu Y; Fayson S; Smith H; Matrka L
Ann Otol Rhinol Laryngol; 2019 Apr; 128(4):309-315. PubMed ID: 30595025
[TBL] [Abstract][Full Text] [Related]
32. How Enhancing Immunity to Low-Risk HPV Could Cure Recurrent Respiratory Papillomatosis.
Bai K; Allen C
Laryngoscope; 2021 Sep; 131(9):2041-2047. PubMed ID: 33720393
[TBL] [Abstract][Full Text] [Related]
33. Restricted Recruitment of NK Cells with Impaired Function Is Caused by HPV-Driven Immunosuppressive Microenvironment of Papillomas in Aggressive Juvenile-Onset Recurrent Respiratory Papillomatosis Patients.
Wang W; Xi Y; Li S; Liu X; Wang G; Wang H; Pei M; Zhang J; Gui J; Ni X
J Virol; 2022 Oct; 96(19):e0094622. PubMed ID: 36154611
[TBL] [Abstract][Full Text] [Related]
34. Adult-onset recurrent respiratory papillomatosis: a review of disease pathogenesis and implications for patient counseling.
Taliercio S; Cespedes M; Born H; Ruiz R; Roof S; Amin MR; Branski RC
JAMA Otolaryngol Head Neck Surg; 2015 Jan; 141(1):78-83. PubMed ID: 25393901
[TBL] [Abstract][Full Text] [Related]
35. Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population.
Wiatrak BJ; Wiatrak DW; Broker TR; Lewis L
Laryngoscope; 2004 Nov; 114(11 Pt 2 Suppl 104):1-23. PubMed ID: 15514560
[TBL] [Abstract][Full Text] [Related]
36. The role of HPV type in Recurrent Respiratory Papillomatosis.
Donne AJ; Hampson L; Homer JJ; Hampson IN
Int J Pediatr Otorhinolaryngol; 2010 Jan; 74(1):7-14. PubMed ID: 19800138
[TBL] [Abstract][Full Text] [Related]
37. FRET-based detection and genotyping of HPV-6 and HPV-11 causing recurrent respiratory papillomatosis.
Combrinck CE; Seedat RY; Burt FJ
J Virol Methods; 2013 May; 189(2):271-6. PubMed ID: 23473839
[TBL] [Abstract][Full Text] [Related]
38. [Research status of human papillomavirus vaccine for prevention and treatment of respiratory papillomatosis].
Pan XF; Wang J; Xiao Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Feb; 33(2):189-192. PubMed ID: 30808153
[TBL] [Abstract][Full Text] [Related]
39. [Perspectives on recurrent respiratory papillomatosis and human papillomavirus].
Trolle S; Lynggaard CD; Gregersen KG; Baandrup L; Grønhøj C; Buchwald CV
Ugeskr Laeger; 2019 Oct; 181(41):. PubMed ID: 31610833
[TBL] [Abstract][Full Text] [Related]
40. Clinical efficiency of quadrivalent HPV (types 6/11/16/18) vaccine in patients with recurrent respiratory papillomatosis.
Chirilă M; Bolboacă SD
Eur Arch Otorhinolaryngol; 2014 May; 271(5):1135-42. PubMed ID: 24121781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
